Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-24 @ 7:32 PM
NCT ID:
NCT03645603
Eligibility Criteria:
Inclusion Criteria:
* Continuous analgesic and sedative endovenous treatment for at least 5 days
* Invasive or non-invasive mechanical ventilation
* Clinical conditions that allow by clinical judgment the start of analgosedation weaning
* Post-natal age ≥ 7 days and PMA beyond the 37 weeks
* Written informed consent obtained
Exclusion Criteria:
* Hemodynamic instability
* Cardiac bundle-branch block of 2 or 3 degree
* Hypersensitivity to the alpha-agonists
* Persistent fever of unknown origin or sensitivity to malignant hyperthermia
* Use of alpha-agonist (clonidine or dexmedetomidine) in the last 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Days
Maximum Age:
18 Years
Study:
NCT03645603
Study Brief:
Protocol Section:
NCT03645603